(Q53250512)
Statements
Silodosin, a new alpha1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men. (English)
Yukio Homma
Kazuki Kawabe
Masaki Yoshida
Silodosin Clinical Study Group
31 August 2006
98
5
1019-1024
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference